stocks

BioCryst Pharmaceuticals (BCRX) is preparing to announce its financial results for the second quarter of 2025 on August 4th, prior to the market opening. Analysts predict revenues of approximately $148.85 million for the quarter. Earnings per share (EPS) are projected to be around 3 cents. Analyst Estimates and Trends Recent analyst sentiment has seen some […]